| Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ... International journal of antimicrobial agents 56 (1), 105949, 2020 | 4271 | 2020 |
| Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors B Routy, E Le Chatelier, L Derosa, CPM Duong, MT Alou, R Daillère, ... Science 359 (6371), 91-97, 2018 | 1961 | 2018 |
| Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry P Seng, M Drancourt, F Gouriet, B La Scola, PE Fournier, JM Rolain, ... Clinical Infectious Diseases 49 (4), 543-551, 2009 | 1827 | 2009 |
| Q fever M Maurin, D Raoult Clinical Microbiology Review 12 (4), 518-553, 1999 | 1797 | 1999 |
| Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota M Vétizou, JM Pitt, R Daillère, P Lepage, N Waldschmitt, C Flament, ... Science 350 (6264), 1079-1084, 2015 | 1664 | 2015 |
| 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates M Drancourt, C Bollet, A Carlioz, R Martelin, JP Gayral, D Raoult Journal of clinical microbiology 38 (10), 3623-3630, 2000 | 1261 | 2000 |
| Ticks and tickborne bacterial diseases in humans: an emerging infectious threat P Parola, D Raoult Clinical infectious diseases 32 (6), 897-928, 2001 | 1254 | 2001 |
| Tick-borne rickettsioses around the world: emerging diseases challenging old concepts P Parola, CD Paddock, D Raoult Clinical microbiology reviews 18 (4), 719-756, 2005 | 1171 | 2005 |
| Microorganisms resistant to free-living amoebae G Greub, D Raoult Clinical microbiology reviews 17 (2), 413-433, 2004 | 1063 | 2004 |
| Rickettsioses as paradigms of new or emerging infectious diseases. D Raoult, V Roux Clinical microbiology reviews 10 (4), 694-719, 1997 | 1053 | 1997 |
| The 1.2-megabase genome sequence of Mimivirus D Raoult, S Audic, C Robert, C Abergel, P Renesto, H Ogata, B La Scola, ... Science 306 (5700), 1344-1350, 2004 | 1013 | 2004 |
| Update on tick-borne rickettsioses around the world: a geographic approach P Parola, CD Paddock, C Socolovschi, MB Labruna, O Mediannikov, ... Clinical microbiology reviews 26 (4), 657-702, 2013 | 963 | 2013 |
| Microbial culturomics: paradigm shift in the human gut microbiome study JC Lagier, F Armougom, M Million, P Hugon, I Pagnier, C Robert, F Bittar, ... Clinical Microbiology and Infection 18 (12), 1185-1193, 2012 | 894 | 2012 |
| Comparative genomics of multidrug resistance in Acinetobacter baumannii PE Fournier, D Vallenet, V Barbe, S Audic, H Ogata, L Poirel, H Richet, ... PLoS genet 2 (1), e7, 2006 | 871 | 2006 |
| New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? CA Devaux, JM Rolain, P Colson, D Raoult International journal of antimicrobial agents 55 (5), 105938, 2020 | 866 | 2020 |
| Endocarditis due to rare and fastidious bacteria. P Brouqui, D Raoult Clin Microbiol Rev 14 (1), 177-207, 2001 | 809 | 2001 |
| Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 P Colson, JM Rolain, JC Lagier, P Brouqui, D Raoult Int J Antimicrob Agents 55 (4), 105932, 2020 | 803 | 2020 |
| The abundance and variety of carbohydrate-active enzymes in the human gut microbiota A El Kaoutari, F Armougom, JI Gordon, D Raoult, B Henrissat Nature Reviews Microbiology 11 (7), 497-504, 2013 | 799 | 2013 |
| Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients F Armougom, M Henry, B Vialettes, D Raccah, D Raoult PloS one 4 (9), e7125, 2009 | 794 | 2009 |
| A giant virus in amoebae B La Scola, S Audic, C Robert, L Jungang, X de Lamballerie, M Drancourt, ... Science 299 (5615), 2033, 2003 | 777 | 2003 |
